WTW Executive Share Filings & New Life‑Sciences Leader Drive Growth Strategy
Willis Towers Watson’s July 17 Form 4 filings reveal modest executive share moves, strong SEC compliance, and a new life‑sciences leader, underscoring steady governance and growth potential.
4 minutes to read









